Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) Net Margin (2019 - 2025)

Historic Net Margin for Cyclerion Therapeutics (CYCN) over the last 5 years, with Q3 2025 value amounting to 114.97%.

  • Cyclerion Therapeutics' Net Margin changed N/A to 114.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 144.83%, marking a year-over-year increase of 14025900.0%. This contributed to the annual value of 8697.64% for FY2022, which is 72974700.0% down from last year.
  • As of Q3 2025, Cyclerion Therapeutics' Net Margin stood at 114.97%.
  • Cyclerion Therapeutics' 5-year Net Margin high stood at 114.97% for Q3 2025, and its period low was 21604.84% during Q1 2021.
  • For the 3-year period, Cyclerion Therapeutics' Net Margin averaged around 4222.73%, with its median value being 1826.16% (2022).
  • In the last 5 years, Cyclerion Therapeutics' Net Margin crashed by -196099700bps in 2021 and then skyrocketed by 197786800bps in 2022.
  • Quarter analysis of 3 years shows Cyclerion Therapeutics' Net Margin stood at 2690.06% in 2021, then tumbled by -63bps to 4389.87% in 2022, then skyrocketed by 97bps to 114.97% in 2025.
  • Its last three reported values are 114.97% in Q3 2025, 1797.85% for Q2 2025, and 1798.77% during Q1 2025.